Perspective Therapeutics (CATX) Total Non-Current Liabilities (2011 - 2026)

Perspective Therapeutics has disclosed Total Non-Current Liabilities across 16 years of filings, most recently posting $62.9 million for Q1 2026.

• Total Non-Current Liabilities for Q1 2026 came in at $62.9 million, up 41.15% year-over-year; the trailing twelve-month figure through Mar 2026 was $62.9 million (up 41.15% YoY), and the FY2025 annual result was $59.6 million, up 18.22% from the prior year.
• Total Non-Current Liabilities came in at $62.9 million for Q1 2026 at Perspective Therapeutics, up from $59.6 million in the prior quarter.
• In the past five years, Total Non-Current Liabilities ranged from a high of $62.9 million in Q1 2026 to a low of $2.3 million in Q1 2022.
• The 5-year median for Total Non-Current Liabilities is $33.6 million (2023), against an average of $30.5 million.
• Across the five-year window, Total Non-Current Liabilities surged 713.47% in 2023 and dropped 16.57% in 2025, its largest moves.
• Perspective Therapeutics' Total Non-Current Liabilities stood at $2.8 million in 2022, then soared by 713.47% to $22.7 million in 2023, then surged by 121.81% to $50.4 million in 2024, then increased by 18.22% to $59.6 million in 2025, then climbed by 5.61% to $62.9 million in 2026.
• The last three Total Non-Current Liabilities figures came in at $62.9 million (Q1 2026), $59.6 million (Q4 2025), and $52.3 million (Q3 2025), per Business Quant data.